Colombo, Sept. 4 (Daily Mirror) - The Cabinet has approved the procurement of 120,000 vials of Human Immunoglobulin BP (5–6 grams) for intravenous use, required for the treatment of patients with ...

Some Chinese companies now racing to make generic versions of Novo Nordisk's Wegovy also supplied ingredients for more than a billion makeshift doses of weight-loss drugs sold online in the US over ...

MAHWAH, N.J., Sept. 2, 2025 /PRNewswire/ -- Glenmark Pharmaceuticals Inc., USA (Glenmark) is pleased to announce the upcoming launch 1 of Eribulin Mesylate Injection, 1 mg/2 mL (0.5 mg/mL) Single-Dose ...

FDA approves Teva’s first generic GLP-1 drug for weight loss, based on Novo Nordisk’s Saxenda. Saxenda recorded $165 million in annual sales as of June 2025. See the trading strategy with a perfect ...

Suspicions arose when blood drops, consistent with intravenous drug use, were found in a fire station bathroom used by Thompson. A significant increase in the department's purchases of fentanyl and ...

Simtra plans to invest hundreds of millions of dollars in Bloomington to expand its pharmaceutical manufacturing capacity. Simtra specializes in filling syringes and vials with medications for chronic ...

The mad rush for safe and effective obesity drugs has winners—including Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy—and losers. Here are five molecules that never made it to the market.

Forbes contributors publish independent expert analyses and insights. Bruce Y. Lee, M.D., MBA, covers health, medicine, wellness and science ...

President Trump’s planned pharmaceutical tariffs threaten to hit many of the most common and well-known drugs that Americans take. By Rebecca Robbins and Jonathan Corum President Trump’s repeated ...

Aug 22 (Reuters) - This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign up ...

A drug dealer has been jailed after a stash of cocaine was found hidden in the steering column of a moped he was riding. Victor Pereria Da Luz was followed by undercover patrols in Tunbridge Wells on ...

With top-line phase 3 results in sight, Rezolute has stepped up preparations for a planned rare disease launch by appointing Sunil Karnawat as its chief commercial officer. Rezolute recently completed ...